Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences
NCT05737836 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-06-12
Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Ulcerative Colitis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Ulcerative Colitis patients.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-31
- Primary Completion
- 2025-03-31
- Completion
- 2026-03-31
More Related Trials
-
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
NCT05702879 ·Status: RECRUITING
-
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis
NCT02227342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
NCT00968721 ·Status: TERMINATED
-
Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis
NCT04926103 ·Status: RECRUITING ·Phase: NA
-
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
NCT07177209 ·Status: ACTIVE_NOT_RECRUITING
-
Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures
NCT05579483 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nicotinamide Riboside in Ulcerative Colitis
NCT05561738 ·Status: RECRUITING ·Phase: NA
-
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
NCT00573794 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
NCT02435160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
NCT00385736 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336 ·Status: RECRUITING ·Phase: PHASE2
-
A Gratitude Intervention in Improving Well-being and Coping in People Living With Inflammatory Bowel Disease
NCT03059186 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
NCT01461317 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
NCT01453491 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression
NCT05030064 ·Status: UNKNOWN ·Phase: NA
-
IBD Strong Peer2Peer for Self-Management of Psychological Distress
NCT05722236 ·Status: RECRUITING ·Phase: NA
-
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
NCT01676324 ·Status: COMPLETED
-
Randomized-controlled Trial of Yoga for Ulcerative Colitis
NCT02043600 ·Status: COMPLETED ·Phase: NA
-
Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess
NCT02856763 ·Status: COMPLETED
-
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
NCT05743153 ·Status: UNKNOWN ·Phase: NA
-
Fatigue Management in Quiescent IBD
NCT02709434 ·Status: UNKNOWN ·Phase: NA
-
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678 ·Status: COMPLETED
-
Faecal Microbiota Transplantation in Ulcerative Colitis
NCT01896635 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA